Biogen inks Alzheimer's deal with Eisai

Biogen Idec has entered into a deal to co-develop potential drugs for Alzheimer’s disease with Japanese drug maker Eisai Co...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.